首页> 外文期刊>The Journal of Immunology: Official Journal of the American Association of Immunologists >Suppressive effects of recombinant human monokine induced by IFN-gamma (rHuMig) chemokine on the number of committed and primitive hemopoietic progenitors in liquid cultures of CD34+ human bone marrow cells.
【24h】

Suppressive effects of recombinant human monokine induced by IFN-gamma (rHuMig) chemokine on the number of committed and primitive hemopoietic progenitors in liquid cultures of CD34+ human bone marrow cells.

机译:干扰素-γ(rHuMig)趋化因子诱导的重组人单因子对CD34 +人骨髓细胞液体培养物中定型和原始造血祖细胞数量的抑制作用。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Studies in this report investigated potential hemopoietic suppressive effects of human monokine induced by IFN-gamma (HuMig), a CXC chemokine that is chemotactic for activated lymphocytes. rHuMig was purified from Trichoplusia ni cells after infection with a recombinant baculovirus. The recombinant protein was added to liquid cultures of CD34+ human marrow cells stimulated with IL-3 alone or with both IL-3 and either insulin-like growth factor II (IGF-II) or stem cell growth factor (SCF). The number of committed progenitors, colony-forming units for granulocytes and macrophages (CFU-GM), and primitive progenitors, long term culture-initiating cells (LTC-IC) derived from liquid cultures of CD34+ cells, was determined. rHuMig abrogated the IGF-II-dependent enhancement of CFU-GM and long term culture-initiating cell numbers. Additional studies demonstrated that in liquid cultures of CD34+ cells both rHuMig and IFN-inducible protein-10, another CXC chemokine that is related to HuMig, inhibited the production or expansion of CFU-GM. For a subset of marrows, rHuMig also abrogated SCF enhancement of CFU-GM numbers in cultures of CD34+ cells stimulated with both IL-3 and SCF. These studies are the first to demonstrate that rHuMig can act as a negative regulator of in vitro hemopoiesis, that both rHuMig and IP-10 can suppress an increase in the number of committed progenitors from CD34+ cells, and that chemokines can abrogate hemopoietic stimulatory effects of IGF-II.
机译:本报告中的研究调查了由IFN-γ(HuMig)诱导的人单因子的潜在造血抑制作用,IFN-γ是一种CXC趋化因子,对活化的淋巴细胞具有趋化性。用重组杆状病毒感染后,从毛滴虫ni细胞中纯化rHuMig。将重组蛋白添加到单独用IL-3或用IL-3和胰岛素样生长因子II(IGF-II)或干细胞生长因子(SCF)刺激的CD34 +人骨髓细胞的液体培养物中。确定了定殖祖细胞,粒细胞和巨噬细胞集落形成单位(CFU-GM)的数量以及原始祖细胞,衍生自CD34 +细胞液体培养的长期培养起始细胞(LTC-IC)的数量。 rHuMig废除了CFU-GM的IGF-II依赖性增强作用和长期培养起始细胞数。其他研究表明,在CD34 +细胞的液体培养物中,rHuMig和IFN诱导型蛋白10(与HuMig相关的另一种CXC趋化因子)均抑制CFU-GM的产生或扩增。对于骨髓的一个子集,rHuMig还废除了用IL-3和SCF刺激的CD34 +细胞培养物中CFU-GM数量的SCF增强。这些研究首次证明rHuMig可以作为体外造血的负调节剂,rHuMig和IP-10都可以抑制CD34 +细胞中定型祖细胞数量的增加,并且趋化因子可以消除CD34 +细胞的造血刺激作用。 IGF-II。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号